Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ala Wai Pharma
AddedFeb 18, 2024
UpdatedJun 18, 2026
Ala Wai Pharma

Ala Wai Pharma

Closed

Ala Wai Pharma: Innovating drug delivery systems for enhanced influenza treatment since 2011.

HQ
Honolulu, HI, US
Founded
2011
Overview
Compare
Fundraising
Employees

Ala Wai Pharma, founded in 2011 and headquartered in Honolulu, Hawaii, develops advanced drug delivery systems aimed at increasing the effectiveness of influenza medications. Their innovative methodologies focus on enhancing drug permeability and activation upon entering the bloodstream, ensuring patients receive optimal therapeutic outcomes.

Ala Wai Pharma's work has significantly impacted the pharmaceutical industry by improving the efficacy of influenza treatments. Their cutting-edge delivery systems have garnered attention for their potential to revolutionize how medications are administered, contributing to better patient health and treatment success.

Ala Wai Pharma - Similar Companies

Aktivax logo

Aktivax

aktivax.com

Alavita Pharmaceuticals logo

Alavita Pharmaceuticals

alavita.lu

NovaDel Pharma logo

NovaDel Pharma

Wilmington Pharmaceuticals logo

Wilmington Pharmaceuticals

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Ezra Innovations logo

Ezra Innovations

ezrapharma.com

Aliva Biopharmaceuticals logo

Aliva Biopharmaceuticals

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Aldea Pharmaceuticals logo

Aldea Pharmaceuticals

PharmaIN logo

PharmaIN

pharmain.com

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

Gemmus Pharma logo

Gemmus Pharma

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Ala Wai Pharma - Quick Facts

Who are Ala Wai Pharma's competitors?

Companies similar to Ala Wai Pharma include Aktivax, Alavita Pharmaceuticals, NovaDel Pharma and Wilmington Pharmaceuticals.

When was Ala Wai Pharma founded?

Ala Wai Pharma was founded in 2011.

Where is Ala Wai Pharma's headquarters located?

Ala Wai Pharma's headquarters is located in Honolulu, HI, US.

When was Ala Wai Pharma's last funding round?

Ala Wai Pharma's most recent funding round was for $500k (USD) in August 2013.

How much has Ala Wai Pharma raised to-date?

As of Aug 5, 2013, Ala Wai Pharma has raised a total of $800k (USD).

Ala Wai Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Small Business
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations